KRYS,Krystal Biotech, Inc. | Healthcare

Healthcare

KRYS

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Krystal Biotech, Inc.KRYS

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States.

It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis.

The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions.

Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Latest News >

Euro zone government bond yields drop ahead U.S. inflation data, Fed

Jun 12, 2024

June 12 (Reuters) - Euro zone government bond yields dropped on Wednesday as investors' focus shifted to the release of key U.S. inflation data and the outcome of the Federal Reserve policy meeting later in the session. French and Southern European borrowing costs had risen to their highest levels in around seven months on Tuesday on fears that gains by...

Zillow Group Insider Bought Shares Worth $99,966,743, According to a Recent SEC Filing

Jun 12, 2024

03:17 AM EDT, 06/12/2024 (MT Newswires) -- Jay C Hoag, Director, on June 07, 2024, executed a purchase for 2,338,036 shares in Zillow Group ( ZG ) for $99,966,743. Following the Form 4 filing with the SEC, Hoag has control over a total of 5,955,569 shares of the company, with 9,116 shares held directly and 5,946,453 controlled indirectly. SEC Filing:...

Warby Parker Insider Sold Shares Worth $1,275,122, According to a Recent SEC Filing

Jun 12, 2024

03:18 AM EDT, 06/12/2024 (MT Newswires) -- Neil Harris Blumenthal, Director, Co-Chief Executive Officer, on June 07, 2024, sold 76,582 shares in Warby Parker ( WRBY ) for $1,275,122. Following the Form 4 filing with the SEC, Blumenthal has control over a total of 412,177 shares of the company, with 12,177 shares held directly and 400,000 controlled indirectly. SEC Filing:...

EU to impose tariffs of up to 25% on Chinese EVs, FT reports

Jun 12, 2024

June 12 (Reuters) - The European Commission will notify car makers on Wednesday that it will provisionally apply additional duties of up to 25% on imported Chinese electric vehicles from next month, the Financial Times reported, citing people familiar with the matter. Analysts have said they expect tariffs of between 10% and 25% on Chinese EVs, a move likely to...